ArticleClinical kidney journal2025

The use of SGLT2 inhibitors and GLP-1 receptor agonists in older patients: a debate on approaches in CKD and non-CKD populations.

Sophie Liabeuf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.